APcK 110
CAS: 1001083-74-4
Ref. 3D-BQB08374
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Product Information
APCK-110 is a tyrosine kinase inhibitor that has been shown to inhibit the constitutive activation of the mastocytosis receptor tyrosine kinase, KIT. APCK-110 has also demonstrated efficacy in clinical studies involving patients with leukemia who were resistant to imatinib and dasatinib. The drug inhibits proliferation of cancer cells, and may also be able to differentiate between leukemias and stem cells. The drug has been shown to have toxicities, such as anemia, neutropenia, thrombocytopenia, and hepatotoxicity. These toxicities are dose-dependent, with the most severe side effects seen at high doses.
Chemical properties
Technical inquiry about: 3D-BQB08374 APcK 110
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.